Quick Takeaways
- Medtronic plc filed SCHEDULE 13D for Anteris Technologies Global Corp. Common Stock (AVR).
- Disclosed ownership: 16%.
- Date of event: 22 Jan 2026.
Medtronic plc - 22 Jan 2026 SCHEDULE 13D Report for Anteris Technologies Global Corp. Common Stock (AVR)
- Filing Manager
- Medtronic plc
- Reporting Manager
- Medtronic plc
- Symbol
- AVR
- Shares outstanding
- 96,618,352 shares
- Disclosed Ownership
- 15,652,173 shares
- Ownership
- 16%
- Form type
- SCHEDULE 13D
- Filing time
- 29 Jan 2026, 17:06:28 UTC
- Date of event
- 22 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Medtronic plc disclosed 16% ownership in Anteris Technologies Global Corp. Common Stock (AVR) on 22 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Jan 2026, 17:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 16% | 15,652,173 | 0 | 15,652,173 | /s/ Brian Sandstrom | Brian Sandstrom/Assistant Secretary | 0001613103 |
| Covidien Group S.a.r.l. | 16% | 15,652,173 | 0 | 15,652,173 | /s/ Salvador Sens | Salvador Sens/General Manager | 0001463363 |